Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Bioregenx (BRGX) Accumulated Depreciation & Amortization (2023 - 2024)

Bioregenx has reported Accumulated Depreciation & Amortization over the past 2 years, most recently at $12377.0 for Q3 2024.

  • For Q3 2024, Accumulated Depreciation & Amortization rose 937.47% year-over-year to $12377.0; the TTM value through Sep 2024 reached $12377.0, up 937.47%, while the annual FY2023 figure was $3579.0, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2024 was $12377.0 at Bioregenx, up from $7642.0 in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $20661.0 in Q1 2024 and troughed at $1193.0 in Q3 2023.